Patterns of Use of Perioperative Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass
Author(s) -
Benjamin Drenger,
Manuel L. Fontes,
Yinghui Miao,
Joseph P. Mathew,
Yaacov Gozal,
Solomon Aronson,
Cynthia Dietzel,
Dennis T. Mangano
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.059527
Subject(s) - medicine , odds ratio , confidence interval , coronary artery bypass surgery , cardiology , perioperative , cardiopulmonary bypass , coronary artery disease , prospective cohort study , surgery , anesthesia , artery
Despite proven benefit in ambulatory patients with ischemic heart disease, the pattern of use of angiotensin-converting enzyme inhibitors (ACEIs) in coronary artery bypass graft surgery has been erratic and controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom